COGENTIX MEDICAL INC /DE/ Financial Statements (2026 and earlier)

Company Profile

Business Address 5420 FELTL ROAD
MINNETONKA, MN 55343
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments26,03224,70721,64022,9434,2382,867
Cash and cash equivalent15,37610,4315,7049,3704,2382,867
Short-term investments10,65714,27515,93613,573  
Receivables7,1797,3136,7286,7716,7696,482
Inventory, net of allowances, customer advances and progress billings7,3767,2357,6117,2356,2225,681
Inventory7,3767,2357,6117,2356,2225,681
Other current assets988616702572563774
Other undisclosed current assets     1,351 
Total current assets:41,57539,87136,68037,52019,14415,804
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization2,4662,1862,0762,1152,2022,305
Long-term investments and receivables7192,2184,1865,344  
Long-term investments7192,2184,1865,344  
Intangible asset, including goodwill, after accumulated amortization27,12127,05327,64228,23228,82329,414
Goodwill19,15118,75018,75018,75018,75018,750
Intangible asset, excluding goodwill, after accumulated amortization7,9708,3038,8929,48310,07310,664
Other undisclosed noncurrent assets2,161162161163300289
Total noncurrent assets:32,46731,62034,06635,85531,32632,009
TOTAL ASSETS:74,04271,49170,74573,37550,46947,813
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,4946,5536,5988,3119,4347,621
Taxes payable726915511329834
Employee-related liabilities3,8903,5373,1814,6715,0764,339
Accounts payable2,0521,6441,9882,6893,0852,313
Accrued liabilities8271,2811,374838975936
Debt 198     
Deferred revenue and credits760630632598  
Other undisclosed current liabilities 507   621345
Total current liabilities:8,9597,1827,2308,90910,0557,966
Noncurrent Liabilities
Long-term debt and lease obligation 289   24,17323,891
Long-term debt, excluding current maturities 289   24,17323,891
Liabilities, other than long-term debt1,1751,0371,1131,2271,4312,481
Deferred revenue and credits600614627639648657
Accounts payable and accrued liabilities      936
Liability, pension and other postretirement and postemployment benefits245360325309663735
Other liabilities33062160279120154
Other undisclosed noncurrent liabilities     1,019 
Total noncurrent liabilities:1,4641,0371,1131,22726,62326,372
Total liabilities:10,4238,2198,34310,13536,67834,338
Equity
Equity, attributable to parent63,61963,27262,40263,24013,79213,475
Common stock609609604604265260
Additional paid in capital145,661145,227144,895144,43076,86376,653
Accumulated other comprehensive loss(583)(656)(770)(789)(902)(897)
Accumulated deficit(82,068)(81,908)(82,328)(81,006)(62,436)(62,542)
Total equity:63,61963,27262,40263,24013,79213,475
TOTAL LIABILITIES AND EQUITY:74,04271,49170,74573,37550,46947,813

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
Revenues
(Revenue, Net)		13,76514,06412,95013,23213,40813,005
Cost of revenue
(Cost of Product and Service Sold)		(4,370)(4,658)(4,494)(3,990)(4,370)(4,087)
Gross profit:9,3959,4068,4569,2429,0388,917
Operating expenses(9,589)(9,026)(9,672)(8,768)(8,517)(11,170)
Operating income (loss):(195)380(1,216)475521(2,252)
Nonoperating income (expense)6110159(18,952)(396)(394)
Gain (loss), foreign currency transaction, before tax33313 (15)(18)
Interest and debt expense    (17,694)(381)(376)
Other undisclosed income from continuing operations before equity method investments, income taxes    17,694381376
Income (loss) from continuing operations before equity method investments, income taxes:(134)481(1,157)(18,477)125(2,646)
Other undisclosed loss from continuing operations before income taxes      
Income (loss) from continuing operations before income taxes:(134)481(1,157)(18,477)125(2,646)
Income tax expense (benefit)(26)(62)(53)(93)(19)(19)
Income (loss) from continuing operations:(160)420(1,210)(18,570)106(2,665)
Income (loss) before gain (loss) on sale of properties:(160)420(1,210)(18,570)106(2,665)
Net income (loss) available to common stockholders, diluted:(160)420(1,210)(18,570)106(2,665)

Comprehensive Income ($ in thousands)
Annual | Quarterly

12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
Net income (loss):(160)420(1,210)(18,570)106(2,665)
Comprehensive income (loss):(160)420(1,210)(18,570)106(2,665)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent7311320113(4)(38)
Comprehensive income (loss), net of tax, attributable to parent:(87)533(1,191)(18,458)102(2,703)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: